CA2163114A1 - Peptides exhibiting oxytocin antagonistic activity - Google Patents

Peptides exhibiting oxytocin antagonistic activity

Info

Publication number
CA2163114A1
CA2163114A1 CA002163114A CA2163114A CA2163114A1 CA 2163114 A1 CA2163114 A1 CA 2163114A1 CA 002163114 A CA002163114 A CA 002163114A CA 2163114 A CA2163114 A CA 2163114A CA 2163114 A1 CA2163114 A1 CA 2163114A1
Authority
CA
Canada
Prior art keywords
peptide
pharmaceutical composition
composition according
alpha
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002163114A
Other languages
English (en)
French (fr)
Inventor
Carl-Johan Aurell
Per Melin
Anders Nilsson
Jerzy Trojnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2163114A1 publication Critical patent/CA2163114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002163114A 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity Abandoned CA2163114A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302414A SE501678C2 (sv) 1993-07-13 1993-07-13 Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE9302414-9 1993-07-13

Publications (1)

Publication Number Publication Date
CA2163114A1 true CA2163114A1 (en) 1995-01-26

Family

ID=20390606

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002163114A Abandoned CA2163114A1 (en) 1993-07-13 1994-07-07 Peptides exhibiting oxytocin antagonistic activity

Country Status (16)

Country Link
EP (1) EP0791012A1 (cs)
JP (1) JPH09502427A (cs)
KR (1) KR960702848A (cs)
CN (1) CN1126999A (cs)
AU (1) AU676071B2 (cs)
CA (1) CA2163114A1 (cs)
CZ (1) CZ9896A3 (cs)
FI (1) FI960119A7 (cs)
HU (1) HUT74874A (cs)
IL (1) IL110267A0 (cs)
NO (1) NO955059D0 (cs)
PL (1) PL312568A1 (cs)
SE (1) SE501678C2 (cs)
TW (1) TW268009B (cs)
WO (1) WO1995002609A1 (cs)
ZA (1) ZA945090B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604341D0 (sv) * 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
WO2003072597A1 (en) 2002-02-27 2003-09-04 Ferring Bv Intermediates and methods for making heptapeptide oxytocin analogues
WO2017060339A1 (en) 2015-10-06 2017-04-13 Ferring B.V. New methods for making barusiban and its intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501677C2 (sv) * 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Also Published As

Publication number Publication date
PL312568A1 (en) 1996-04-29
KR960702848A (ko) 1996-05-23
HUT74874A (en) 1997-02-28
AU7240694A (en) 1995-02-13
AU676071B2 (en) 1997-02-27
FI960119L (fi) 1996-01-10
EP0791012A1 (en) 1997-08-27
FI960119A0 (fi) 1996-01-10
CN1126999A (zh) 1996-07-17
IL110267A0 (en) 1994-10-21
CZ9896A3 (en) 1996-06-12
JPH09502427A (ja) 1997-03-11
FI960119A7 (fi) 1996-01-10
SE9302414L (sv) 1995-01-14
NO955059L (no) 1995-12-13
SE501678C2 (sv) 1995-04-10
ZA945090B (en) 1995-02-22
WO1995002609A1 (en) 1995-01-26
SE9302414D0 (sv) 1993-07-13
HU9503768D0 (en) 1996-02-28
NO955059D0 (no) 1995-12-13
TW268009B (cs) 1996-01-11

Similar Documents

Publication Publication Date Title
US6143722A (en) Heptapeptide oxytocin analogues
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
HU224345B1 (hu) Növekedési hormont felszabadító tulajdonságú peptidek, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
JPS63154699A (ja) バソプレシン拮抗剤
JP2001523232A (ja) GnRH拮抗物質
JPS6396199A (ja) バソプレシン拮抗剤
SE501677C2 (sv) Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
JPS61191698A (ja) 新規な環状ヘキサペプチドlhrh拮抗剤
Theobald et al. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N. omega.-cyanoguanidino moieties
EP0269299A2 (en) Atrial peptides
CA2405704C (en) Bombesin analogs for treatment of cancer
US6316414B1 (en) Somatostatin analogs for the treatment of cancer
AU676071B2 (en) Peptides exhibiting oxytocin antagonistic activity
EP1198478B1 (en) Somatostatin analogs and their use for the treatment of cancer
JPS61293999A (ja) バソプレシン拮抗剤
AU8225191A (en) Derivatives of pituitary posterior lobe hormones
JPS62209096A (ja) バソプレシン化合物
US6989371B1 (en) Bombesin analogs for treatment of cancer
JPS63303999A (ja) バソプレシン拮抗剤
CA2008454A1 (en) Linear analog of biologically active mammalian grp or amphibian bombesin
HK1006947A1 (en) Treatment of liver cancer
HK1006947B (en) Treatment of liver cancer
ITMI951293A1 (it) Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della

Legal Events

Date Code Title Description
FZDE Discontinued